Gregory S. Calip

Jan 8, 2024 | jnccn.org | Hsiao-Ching Huang |Gregory S. Calip |Jennifer Weiss |Yael Simons

Background The Oncotype 21-gene breast recurrence score (RS) is the most commonly ordered multigene breast cancer biomarker in the United States,1 and the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer base its recommendations on the RS for patients with estrogen receptor (ER)–positive, HER2-negative tumors (henceforth referred to as ER-positive) that do not have axillary lymph node metastases.2 The 21-gene RS was developed as a predictive biomarker because...

Dec 20, 2023 | nature.com | Andrew Hantel |Gregory S. Calip |Daniel DeAngelo

AbstractInequitable uptake of novel therapies (NT) in non-cancer settings are known for patients with lower socioeconomic status (SES), People of Color (POC), and older adults. NT uptake equity in acute myeloid leukemia (AML) is not well known. We performed a retrospective cohort study (1/2014-8/2022) of the United States nationwide Flatiron HealthTM electronic health record-derived, de-identified database.

Aug 17, 2023 | healio.com | Jennifer Southall |Mindy Valcarcel |Gregory S. Calip |Joseph M. Unger

Source/Disclosures Disclosures: Pittell reports employment with Flatiron Health and stock ownership in Roche during the conduct of the study. Please see the study for all other authors’ relevant financial disclosures. Unger reports no relevant financial disclosures. You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later.

Jul 21, 2023 | healio.com | Jennifer Southall |Mindy Valcarcel |Gregory S. Calip |Joseph M. Unger

Source/Disclosures Disclosures: Pittell reports employment with Flatiron Health and stock ownership in Roche during the conduct of the study. Please see the study for all other authors’ relevant financial disclosures. Unger reports no relevant financial disclosures. You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later.